| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091776733 |
| P356 | DOI | 10.1186/S12957-017-1243-Z |
| P932 | PMC publication ID | 5602959 |
| P698 | PubMed publication ID | 28915886 |
| P50 | author | Bengt Glimelius | Q30830855 |
| Peter Nygren | Q66206118 | ||
| P2093 | author name string | Magnus Sundbom | |
| Haile Mahteme | |||
| Bo Hultman | |||
| Ulf Gunnarsson | |||
| P2860 | cites work | Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer | Q67510956 |
| Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer | Q68786514 | ||
| Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
| Administration in a hypotonic solution is preferable to dose escalation in intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in rats | Q77961992 | ||
| Effect of folic acid, 4-amino folic acids and related substances on growth of chick embryo | Q80357985 | ||
| Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy | Q83903423 | ||
| Effects of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy and Neoadjuvant Intraperitoneal/Systemic Chemotherapy on Peritoneal Metastases from Gastric Cancer | Q88091218 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
| Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial | Q29620917 | ||
| Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program | Q30313895 | ||
| Capecitabine and oxaliplatin for advanced esophagogastric cancer. | Q33313072 | ||
| Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction | Q33380002 | ||
| Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial | Q34634440 | ||
| Gastric cancer epidemiology and risk factors | Q35067625 | ||
| Gastric cancer: epidemiology, pathology and treatment. | Q35156153 | ||
| Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent. | Q36674050 | ||
| Metastatic spread in patients with gastric cancer | Q37588449 | ||
| Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis | Q37676972 | ||
| Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. | Q37768362 | ||
| The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows. | Q38269169 | ||
| Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. | Q38675685 | ||
| Prognostic Factors for Gastric Cancer with Cancer Cells in the Peritoneal Cavity | Q39811374 | ||
| Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial | Q40046733 | ||
| Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery | Q43288249 | ||
| Significance of palliative gastrectomy for late-stage gastric cancer patients | Q44681408 | ||
| The pattern and risk factors of recurrence of proximal gastric cancer after curative resection | Q45761358 | ||
| Gastric carcinoma. | Q52230682 | ||
| Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
| Tumor load and surgical palliation in gastric cancer. | Q54451514 | ||
| The Value of Peritoneal Cytology as a Preoperative Predictor in Patients With Gastric Carcinoma Undergoing a Curative Resection | Q57846301 | ||
| Value of palliative resection in gastric cancer | Q62628725 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 172 | |
| P577 | publication date | 2017-09-15 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Prognostic factors in patients with loco-regionally advanced gastric cancer | |
| P478 | volume | 15 |
| Q52805995 | [Surgical treatment of peritoneal metastases of gastric cancer]. | cites work | P2860 |
Search more.